Dr Claudia Compagnucci is leading the iPS group at Bambino Gesù Children's Hospital and this group is involved in reprogramming somatic cells (fibroblasts and blood cells) of patients with different rare genetic disorders into iPSCs to perform morphofunctional characterization of the cell type of interest. Dr Compagnucci gained this role following her previous experience in the field of developmental biology and stem cells, and she is using these skills to shed light on the physio-pathology of several neurological diseases. Dr Compagnucci is continously increasing her knowledge with the aim to develop in vitro treatments with a potential beneficial effect to human patients.
Dr Claudia Compagnucci is leading the iPS group at Bambino Gesù Children's Hospital and this group is involved in reprogramming somatic cells (fibroblasts and blood cells) of patients with different rare genetic disorders into iPSCs to perform morphofunctional characterization of the cell type of interest. Dr Compagnucci gained this role following her previous experience in the field of developmental biology and stem cells, and she is using these skills to shed light on the physio-pathology of several neurological diseases. Dr Compagnucci is continously increasing her knowledge with the aim to develop in vitro treatments with a potential beneficial effect to human patients.